In Section A, contributors will receive diverse doses and schedules of oral ABBV-744 pill to determine Safe and sound dosing regimen. Additional individuals are going to be enrolled on the determined monotherapy dosign program. In Phase B, participants will receive oral ruxolitinib and ABBV-744 might be given as "insert-on" therapy. https://aabyey183vro4.ziblogs.com/profile